Successful treatment with fingolimod of graft-versus-host disease of the central nervous system.

Jordan GauthierPatrick VermerschPaul ChauvetPauline VarletValérie CoiteuxLeonardo MagroIbrahim Yakoub-Agha

Published in: Blood advances (2018)

Fingolimod could be efficient to treat GVHD of the central nervous system.Further research should explore the use of fingolimod and other sphingosine-1-phosphate receptor agonists to prevent or treat GVHD.

Keyphrases

multiple sclerosis
allogeneic hematopoietic stem cell transplantation
cerebrospinal fluid